Trial Scorecards
Trial Scorecards
May 19, 2020
1 min read
Save

ENAVLE

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Occurrence of thromboembolic events in patients taking edoxaban (Savaysa, Daiichi Sankyo) vs. warfarin after bioprosthetic valve implantation or repair.